Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company CDG Therapeutics Inc.
DescriptionA non-mdm2 p53 binding protein homolog (MDM2; HDM2) mediated peptide inhibitor of p53 ubiquitination
Molecular Target Mdm2 p53 binding protein homolog (MDM2) (HDM2)
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationSolid tumors
Indication DetailsTreat metastatic refractory solid tumors
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today